Atara Biotherapeutics, Inc. operates as a clinical stage company which focuses on developing novel therapeuti... More | Chart | Post
Full Profile of ATRA (Atara Biotherapeutics, Inc.) : Nasdaq
Market Cap: 1.55B | Industry: Health Care/Life Sciences
Atara Biotherapeutics, Inc. operates as a clinical stage company which focuses on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin...
Atara Biotherapeutics, Inc. operates as a clinical stage company which focuses on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin...